Related Experiment Video
Updated: Jan 23, 2026

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression
Published on: January 19, 2019
Aberrant methylation limits antitumoral inflammation in lung adenocarcinoma by restricting RIPK3 expression
Deepti Agrawal1, Katarina Cisarova2, Sebastian Vosberg2,3,4,5
1Medical Department III, School of Medicine, Technical University of Munich, Munich, Germany.
Abstract:
Evasion of programmed cell death is a critical hallmark of cancer. However, the contribution of inflammatory forms of cell death in lung carcinogenesis and their effects on the composition of the tumor-immune microenvironment remain unclear. Our multi-omics analyses of samples from patients with primary lung adenocarcinoma revealed that necrosome signaling is repressed because of reduced expression of receptor-interacting protein kinase 3 (RIPK3). Distinct methylation signatures, both in the RIPK3 promoter and nonpromoter regions, correlated with lower transcription levels of RIPK3. This resulted in limited expression of inflammatory genes, advanced histologic features, reduced immune cell invasion, and decreased patient survival. Mechanistically, we confirmed the tumor-suppressive role of necrosome signaling through the genetic deletion of Ripk3 in two independent, clinically relevant mouse models of lung adenocarcinoma. Functionally, RIPK3 shaped a diverse immune environment by promoting the invasion of innate and adaptive immune cells in patient samples and experimental mice. Thus, RIPK3-mediated inflammatory signaling enhances a diverse immune microenvironment and hinders progression in lung adenocarcinoma.
Insights
Receptor-interacting protein kinase 3 (RIPK3) represses lung adenocarcinoma progression by activating inflammatory cell death and promoting immune cell invasion. Loss of RIPK3 function correlates with poor patient survival.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- Evasion of programmed cell death is a key cancer mechanism.
- The role of inflammatory cell death in lung cancer and its impact on the tumor-immune microenvironment are not fully understood.
Purpose of the Study:
- To investigate the role of necrosome signaling, specifically receptor-interacting protein kinase 3 (RIPK3), in lung adenocarcinoma development.
- To determine how RIPK3 influences the tumor-immune microenvironment and patient outcomes.
Main Methods:
- Multi-omics analyses of patient samples.
- Analysis of RIPK3 promoter and nonpromoter methylation.
- Genetic deletion of Ripk3 in mouse models of lung adenocarcinoma.
Main Results:
- Reduced RIPK3 expression, linked to methylation changes, was observed in lung adenocarcinoma.
- Lower RIPK3 expression correlated with repressed necrosome signaling, limited inflammatory gene expression, advanced histology, reduced immune cell infiltration, and decreased patient survival.
- Genetic deletion of Ripk3 in mice confirmed its tumor-suppressive role and demonstrated its function in promoting immune cell invasion.
Conclusions:
- RIPK3-mediated inflammatory signaling is crucial for a diverse immune microenvironment in lung adenocarcinoma.
- RIPK3 acts as a tumor suppressor by enhancing immune cell infiltration and hindering tumor progression.
More Related Videos
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
Related Concept Videos
Inflammation
Limiting Reactant
The Number e as a Limit
Restriction Enzymes
The host bacteria protect their own genomic DNA from these enzymes by methylating these sites. Some...
Lung Capacity
Central Limit Theorem
The sample size, n, that...